For the study, Dr. Harper will work with the Alabama Department of Health to assess the effectiveness of in-person opioid agonist therapy versus the same therapy delivered via telemedicine. The telemedicine intervention will use remote video and audio conferencing, alongside supplemental technologies like Bluetooth stethoscopes.
The Society for Maternal-Fetal Medicine awarded its inaugural Aetna Health Policy Award to fund the research project.
In previous studies, opioid agonist therapy has been proven to increase pregnant women’s participation in prenatal care, improving outcomes for both the mother and child by reducing the incidence of relapses. However, treatment is typically offered in-person with a physician, posing a challenge for women in rural areas facing transportation barriers.
“We’re working to reduce health disparities that impact mothers across our state and provide quality care that can help these women lead healthy pregnancies and lives,” Dr. Harper said in a March 14 statement.
More articles on telehealth:
4 study insights into the pediatric telehealth landscape
U of Mississippi Medical Center taps SnapMD for national telehealth center of excellence
Remote therapy improves blood glucose control among teens with Type 1 diabetes, study suggests
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.